argenx SE | Investor Presentation Deck

Slide locked Sign in to view

Slide schematic 7/7

callout 1/1 diagram 1/1 image 1/1 list 1/1 paragraph 1/1 source-note 1/1 title 1/1

Components 7

primary timeline logo bullet paragraph source-note headline

Tools 2

AIDA Model slide · 70%

Primary endpoint: Sustained platelet count (≥50x10^9/L) in ≥4/6 visits between weeks 19 and 24.

SCQA Framework slide · 60%

Primary endpoint: Sustained platelet count (≥50x10^9/L) in ≥4/6 visits between weeks 19 and 24.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

timeline 90%

Visual representation of trial phases over 24 weeks

Find anything